» Articles » PMID: 34337577

Minielectrode Catheter Technology for Near Zero-fluoroscopy Substrate-guided Ablation of Typical Atrial Flutter

Overview
Journal Heart Rhythm O2
Date 2021 Aug 2
PMID 34337577
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroFidelity catheter technology may facilitate voltage-guided ablation by high-resolution electroanatomic mapping (HR-EAM) and precisely targeted energy application.

Objective: To evaluate the performance of minielectrode (ME) technology for zero-fluoroscopy substrate-guided cavotricuspid isthmus (CTI) ablation.

Methods: Eighty-two patients underwent near zero-fluoroscopy substrate-guided CTI ablation using a nonirrigated large-tip catheter with 3 MEs. The CTI was subdivided into 15 electroanatomic segments. Bipolar voltage maps were compared with ME signals. The outcome was compared with a historic cohort of 92 patients who underwent linear ablation.

Results: Compared with linear ablation, the substrate-guided approach was associated with an almost halved ablation duration (336 ± 228 vs 649 ± 409 seconds, < .001), halved radiofrequency energy applied (14.2 ± 10.6 vs 28.6 ± 19.6 kJ, < .001), and shorter procedure duration (60.8 ± 33.8 vs 76.3 ± 40.9 minutes, = .008) limiting the extent of energy delivery to 22.7% of the CTI area. HR-EAM visualized 2.03 ± 0.88 conductive pathways with a diameter of 5.35 ± 1.98 mm. A higher number of ME-detected bundles and a larger channel diameter correlated with increased ablation requirements. In 97.6% of the voltage-guided and 88.0% of the linear procedures, fluoroscopy was not used.

Conclusion: HR-EAM-based substrate-guided CTI ablation may improve procedural outcome compared with the linear approach. Enhanced identification of discrete conductive pathways correlates with ablation efficacy. The electroanatomic subdivision of the CTI into 15 segments was feasible and may improve the understanding and comparability of anatomic variants and ablation results. Independent of the ablation strategy, modern EAM technology enables safe zero-fluoroscopy procedures in the majority of cases.

Citing Articles

Magnetic resonance imaging-guided conventional catheter ablation of isthmus-dependent atrial flutter using active catheter imaging.

Ulbrich S, Huo Y, Tomala J, Wagner M, Richter U, Pu L Heart Rhythm O2. 2022; 3(5):553-559.

PMID: 36340492 PMC: 9626877. DOI: 10.1016/j.hroo.2022.06.011.

References
1.
Sato H, Yagi T, Namekawa A, Ishida A, Yamashina Y, Nakagawa T . Efficacy of bundle ablation for cavotricuspid isthmus-dependent atrial flutter: combination of the maximum voltage-guided ablation technique and high-density electro-anatomical mapping. J Interv Card Electrophysiol. 2010; 28(1):39-44. DOI: 10.1007/s10840-010-9468-6. View

2.
Natale A, Newby K, Pisano E, Leonelli F, Fanelli R, Potenza D . Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000; 35(7):1898-904. DOI: 10.1016/s0735-1097(00)00635-5. View

3.
Shah D, Haissaguerre M, Jais P, Takahashi A, Hocini M, Clementy J . High-density mapping of activation through an incomplete isthmus ablation line. Circulation. 1999; 99(2):211-5. DOI: 10.1161/01.cir.99.2.211. View

4.
Page R, Joglar J, Caldwell M, Calkins H, Conti J, Deal B . 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2015; 133(14):e506-74. DOI: 10.1161/CIR.0000000000000311. View

5.
Scavee C, Jais P, Hsu L, Sanders P, Hocini M, Weerasooriya R . Prospective randomised comparison of irrigated-tip and large-tip catheter ablation of cavotricuspid isthmus-dependent atrial flutter. Eur Heart J. 2004; 25(11):963-9. DOI: 10.1016/j.ehj.2004.03.017. View